Breathing therapy tested for heart failure – trial stopped early

NCT ID NCT05223751

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a special breathing exercise program could help people with systolic heart failure walk farther and feel better. The trial planned to enroll 65 adults with moderate heart failure, but it was terminated early. Participants would have been assigned to either standard care or standard care plus daily breathing exercises using a smartphone app and coaching.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
breathing exercises (Meo Health breathing therapy)
What this could lead to
If it worked, this could offer a simple, drug-free way to help people with heart failure feel better and walk farther.
What could go wrong
The trial was terminated early, so we have limited data. It was also a small study, and results may not apply to everyone with heart failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIASTOLIC HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Lancaster General Hospital

    Lancaster, Pennsylvania, 17604, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.